About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:4440459
Allelic
Composition
Cybbtm1Din/Y
Genetic
Background
B6.129S-Cybbtm1Din
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cybbtm1Din mutation (1 available); any Cybb mutation (42 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body

nervous system
• chronic intermittent hypoxia fails to evoke sensory long-term facilitation in the carotid body

renal/urinary system
N
• anesthetized males exhibit no significant differences in baseline glomerular filtration rate (GFR), urine flow, sodium excretion, and potassium excretion relative to wild-type controls
• proportionately greater decrease in renal blood flow after L-NAME administration than in controls
• anesthetized males exhibit significantly higher baseline renal blood flow (RBF) relative to wild-type controls (4.3+/-0.4 versus 2.5+/-0.2 mL/min per gram, respectively)
• in response to i.v. infusion of Ang II, anesthetized males show a smaller % of reduction in RBF relative to wild-type controls (-8% versus -33%, respectively)
• anesthetized males exhibit significantly lower baseline renal vascular resistance (RVR) relative to wild-type controls (16+/-1.3 versus 29+/-2.3 mm Hg/mL/min per gram, respectively) (J:101981)
• in response to i.v. infusion of Ang II, anesthetized males show a smaller % of increase in RVR relative to wild-type controls (+73% versus +173%, respectively) (J:101981)
• after L-NAME administration relative to controls (J:138704)
• conscious males exhibit a higher excretion rate of creatinine relative to wild-type controls (1.4+/-0.4 versus 1.0+/-0.2 mg/day per gram, respectively)
• after L-NAME administration relative to controls
• conscious males exhibit a higher basal level of urinary sodium excretion relative to wild-type controls (807+/-69 versus 545+/-94 umol/day per gram, respectively)
• however, the basal level of 24-hour urine flow is normal in conscious males
• conscious males exhibit significantly higher urinary excretion of nitrate/nitrite relative to wild-type controls (23.7+/-3.0 versus 13.3+/-2.5 umol/day per gram, respectively)
• in response to i.v. infusion of Ang II, anesthetized males show a 43% increase in GFR, unlike wild-type controls where GFR is not significantly altered
• reduced urine volume after L-NAME administration relative to controls

cardiovascular system
N
• anesthetized males exhibit no significant differences in baseline mean arterial pressure relative to wild-type controls
• conscious males show no significant differences in mean systolic arterial pressure relative to wild-type controls
• i.v. administration of Ang II causes similar increments in mean arterial pressure in both genotypes
• proportionately greater decrease in renal blood flow after L-NAME administration than in controls
• anesthetized males exhibit significantly higher baseline renal blood flow (RBF) relative to wild-type controls (4.3+/-0.4 versus 2.5+/-0.2 mL/min per gram, respectively)
• in response to i.v. infusion of Ang II, anesthetized males show a smaller % of reduction in RBF relative to wild-type controls (-8% versus -33%, respectively)
• anesthetized males exhibit significantly lower baseline renal vascular resistance (RVR) relative to wild-type controls (16+/-1.3 versus 29+/-2.3 mm Hg/mL/min per gram, respectively) (J:101981)
• in response to i.v. infusion of Ang II, anesthetized males show a smaller % of increase in RVR relative to wild-type controls (+73% versus +173%, respectively) (J:101981)
• after L-NAME administration relative to controls (J:138704)
• right ventricular systolic pressure is not increased by intermittent hypoxic stress as it is in controls

homeostasis/metabolism
• conscious males exhibit a higher excretion rate of creatinine relative to wild-type controls (1.4+/-0.4 versus 1.0+/-0.2 mg/day per gram, respectively)
• conscious males exhibit a significantly higher 24-hour urinary excretion of NO metabolites, nitrate/nitrite, relative to wild-type controls, indicating an increase in NO bioavailability
• however, no significant changes in urinary excretion of 8-isoprostane (an indirect marker for oxidative stress) are observed
• after L-NAME administration relative to controls
• conscious males exhibit a higher basal level of urinary sodium excretion relative to wild-type controls (807+/-69 versus 545+/-94 umol/day per gram, respectively)
• however, the basal level of 24-hour urine flow is normal in conscious males
• conscious males exhibit significantly higher urinary excretion of nitrate/nitrite relative to wild-type controls (23.7+/-3.0 versus 13.3+/-2.5 umol/day per gram, respectively)

muscle


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/21/2024
MGI 6.23
The Jackson Laboratory